ÂÜÀòÂÒÂ×

Magnus Edlund is an accomplished professional with extensive experience across various industries, including industrial goods, retail banking, pulp and paper, private equity, consumer health, and pharmaceuticals. Currently serving as a Partner at Impilo since September 2017, Magnus holds multiple board positions, including roles at Immedica Pharma AB, Lowenco A/S, VaccinDirekt, and Mallax Pharmaceuticals AB. Previous experience includes significant positions at Orchid Orthopedic Solutions, Altor Equity Partners, and The Boston Consulting Group, where Magnus demonstrated expertise in corporate strategy, strategic due diligence, product development, and customer strategy. Academic credentials include a Master of Science degree in Wireless Communications and Business Administration from the Royal Institute of Technology (KTH) in Sweden and studies at UC San Diego.